Dogwood Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -110.1% | -110.1% | -101.2% |
| FY2022 | -167.2% | -167.2% | -146.3% |
| FY2023 | -139.1% | -139.1% | -127.1% |
| FY2024 | 122.0% | 122.0% | -13.1% |
| FY2025 | -45.7% | -45.7% | -38.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -110.1% | -110.1% | -101.2% |
| FY2022 | -167.2% | -167.2% | -146.3% |
| FY2023 | -139.1% | -139.1% | -127.1% |
| FY2024 | 122.0% | 122.0% | -13.1% |
| FY2025 | -45.7% | -45.7% | -38.0% |